below both of those Drake’s and Lynch’s versions, the price of deleterious mutations is exactly what drives mutation premiums down (Drake 1991; Lynch 2010; Sung et al. 2012). as a result, below both products, a rise in the common expense of mutations would result in a minimize in mutation rates. to look at this, Drake examined mutation prices o